Ryerson Holding Corporation (RYZ) Stock Analysis
Industrials · Metal Fabrication · NYSE
Ryerson Holding Corporation (RYZ) posted $4.57B in revenue for fiscal 2025 (down 0.6% year over year), with a net loss of $56.40M, and has compounded revenue about 5.7%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Ryerson Holding Corporation
Ryerson Holding Corporation has grown revenue from $2.86B to $4.57B over the last 10 fiscal years, compounding about 5.7% a year. The most recent year was down 0.6%, so growth has cooled from its longer-run pace.
Net margin sits at -1.2%, down 1 points year over year on a 17.1% gross margin. It carries about $463.10M of total debt.
At today's valuation the market is pricing in roughly 18% annual free-cash-flow growth — versus the -32.4% it actually delivered over the last five years, so the price already assumes a step-up from the recent record. The one thing worth a second look in the filings is heavy debt load.
Synthesised from Ryerson Holding Corporation's SEC filings — descriptive, not advice. Ask the analyst your own question →
Ryerson Holding Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.86B | $3.36B | $4.41B | $4.50B | $3.47B | $5.68B | $6.32B | $5.11B | $4.60B | $4.57B |
| Gross profit | $570.60M | $582.50M | $758.10M | $827.90M | $621.10M | $1.15B | $1.31B | $1.02B | $834.20M | $782.20M |
| Net income | $18.70M | $17.10M | $106.00M | $82.40M | $-65.80M | $294.30M | $391.00M | $145.70M | $-8.60M | $-56.40M |
| Net margin | 0.7% | 0.5% | 2.4% | 1.8% | -1.9% | 5.2% | 6.2% | 2.9% | -0.2% | -1.2% |
Source: Ryerson Holding Corporation SEC filings (10-K). 17 years of history available in the interactive view.
Ryerson Holding Corporation: 2 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Heavy debt loadTotal debt of $465M is 5.3× last year's operating cash flow — it would take years of cash flow to clear.
- Currently unprofitableThe latest fiscal year was a net loss (net margin -1.2%).
What growth is priced into RYZ stock?
At today's market cap of $1.51B, Ryerson Holding Corporation is priced for free-cash-flow growth of about 18% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $35.50M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -32.4%/yr over the last five fiscal years and revenue 5.7%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 17 years of Ryerson Holding Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track RYZ in your portfolio →
Ryerson Holding Corporation financial history by metric
Compare Ryerson Holding Corporation with peers
About Ryerson Holding Corporation
Ryerson Holding Corporation, together with its subsidiaries, processes and distributes industrial metals in the United States and internationally. It offers a line of products in carbon steel, stainless steel, alloy steels, and aluminum, as well as nickel and red metals in various shapes and forms, including coils, sheets, rounds, hexagons, square and flat bars, plates, structural, and tubing. The company also provides processing services. It serves commercial transportation, fabrication and welding, machinery and equipment, consumer products, heavy equipment, climate, power, and machine shop industries. Ryerson Holding Corporation was founded in 1842 and is headquartered in Chicago, Illinois.
Ryerson Holding Corporation — frequently asked questions
What is Ryerson Holding Corporation's revenue?
Ryerson Holding Corporation (RYZ) reported revenue of $4.57B for fiscal year 2025, down 0.6% from the prior year, according to its SEC filings.
Is Ryerson Holding Corporation profitable?
No — RYZ reported a net loss of $-56.40M in fiscal 2025.
What is RYZ's P/E ratio?
Ryerson Holding Corporation trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Ryerson Holding Corporation growing?
RYZ's revenue grew at roughly 5.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Ryerson Holding Corporation have?
As of fiscal year 2025, RYZ carried roughly $463.10M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Ryerson Holding Corporation's gross margin?
RYZ's gross margin was 17.1% in fiscal 2025 — gross profit of $782.20M on revenue of $4.57B.
What is Ryerson Holding Corporation's market cap?
Ryerson Holding Corporation (RYZ) has a market capitalization of about $1.51B, based on the latest data in our nightly-refreshed cache.
When does Ryerson Holding Corporation's fiscal year end?
RYZ's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into RYZ stock?
At today's market cap of $1.51B, Ryerson Holding Corporation is priced for free-cash-flow growth of about 18% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $35.50M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -32.4%/yr over the last five fiscal years and revenue 5.7%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Ryerson Holding Corporation's official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.